Results 91 to 100 of about 2,101 (161)

Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease. [PDF]

World J Gastrointest Pharmacol Ther
Malakar S, Giri S, Jena A, Nath P.
europepmc   +1 more source

Real-world experience with Janus kinase inhibitors in rheumatoid and psoriatic arthritis: retention and discontinuation factors in a UK six-centre cohort. [PDF]

Rheumatol Adv Pract
Nathan J, Farisogullari B, Jones N, Ayoub M, Brown J, Levy S, Brader J, Ersoy A, Israni B, Lloyd M, Latheef A, Hill D, Taylor A, Arachchige D, Chitsu H, Linklater H, Lather K, Gompels L, Elfar E, Malaiya R, Machado PM, Kiely PDW.   +21 more
europepmc   +1 more source

Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumab. [PDF]

Biologics
Otake H, Matsumoto S, Mashima H.
europepmc   +1 more source

Janus Kinase Inhibitor Discontinuation at a UK Tertiary Centre: A Retrospective Study. [PDF]

Cureus
Bland K, Jubber A, Ganguly S, Moorthy A.
europepmc   +1 more source

Preparation of colon-targeted pellets loaded with filgotinib/berberine hydrochloride and Their application in ulcerative colitis therapy. [PDF]

Int J Pharm X
Wang J, Kuang Z, Chen B, Yan C, Shi B, Li G.   +5 more
europepmc   +1 more source

Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry. [PDF]

RMD Open
Sonomoto K, Nakayamada S, Sakai H, Ueno M, Tanaka H, Nagayasu A, Aritomi T, Okawara M, Nakata A, Tanaka Y.   +9 more
europepmc   +1 more source

Advanced Medical Therapies for Perianal Fistulizing Crohn's Disease: A Systematic Review of Clinical, Radiological, Surgical, and Composite Outcomes. [PDF]

Pharmaceuticals (Basel)
Jamal F, Segun-Omosehin T, Viggiano T, Khan H, Gonzalez AJ, Thomas G, Elmasry S, Malik TA.   +7 more
europepmc   +1 more source

Emerging role of Janus kinase inhibitors in ulcerative colitis management. [PDF]

World J Gastrointest Pharmacol Ther
Ahsan MU, Sajid SL, Balach R, Daniyal M, Ain NU, Mudasir M.   +5 more
europepmc   +1 more source

Filgotinib in the treatment of infl ammatory bowel diseases

Gastroenterologie a hepatologie, 2023
openaire   +1 more source

Monotherapy Versus Combination Therapy of Janus Kinase Inhibitors With Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) in Rheumatoid Arthritis: Evidence From a Systematic Review of Randomized Controlled Trials. [PDF]

Cureus
Mirghani Idris RG, Mohammed Nogod AA, Mohamedalamin E, Ahmed Elhaj FM, Yousif Musa AW, Mohammed Mansoor ME, Elagab EA.   +6 more
europepmc   +1 more source